Attached files
file | filename |
---|---|
EX-32.2 - EX-32.2 - UNIVERSAL DISPLAY CORP \PA\ | oled-ex322_6.htm |
EX-32.1 - EX-32.1 - UNIVERSAL DISPLAY CORP \PA\ | oled-ex321_9.htm |
EX-31.2 - EX-31.2 - UNIVERSAL DISPLAY CORP \PA\ | oled-ex312_7.htm |
EX-31.1 - EX-31.1 - UNIVERSAL DISPLAY CORP \PA\ | oled-ex311_8.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2017
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from ____________ to ___________
Commission File Number 1-12031
UNIVERSAL DISPLAY CORPORATION
(Exact name of registrant as specified in its charter)
Pennsylvania |
|
23-2372688 |
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
375 Phillips Boulevard, Ewing, New Jersey |
|
08618 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: (609) 671-0980
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer |
☒ |
|
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
(Do not check if a smaller reporting company) |
Smaller reporting company |
☐ |
|
|
|
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial account standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of October 30, 2017, the registrant had outstanding 47,040,602 shares of common stock.
PART I – FINANCIAL INFORMATION
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
(UNAUDITED)
(in thousands, except share and per share data)
|
|
September 30, 2017 |
|
|
December 31, 2016 |
|
||
ASSETS |
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
69,153 |
|
|
$ |
139,365 |
|
Short-term investments |
|
|
296,282 |
|
|
|
188,644 |
|
Accounts receivable |
|
|
43,256 |
|
|
|
24,994 |
|
Inventory |
|
|
32,733 |
|
|
|
17,314 |
|
Deferred income taxes |
|
|
— |
|
|
|
8,661 |
|
Other current assets |
|
|
9,227 |
|
|
|
6,392 |
|
Total current assets |
|
|
450,651 |
|
|
|
385,370 |
|
PROPERTY AND EQUIPMENT, net of accumulated depreciation of $35,087 and $32,167 |
|
|
49,358 |
|
|
|
27,203 |
|
ACQUIRED TECHNOLOGY, net of accumulated amortization of $86,162 and $70,714 |
|
|
136,679 |
|
|
|
152,127 |
|
OTHER INTANGIBLE ASSETS, net of accumulated amortization of $1,652 and $615 |
|
|
15,188 |
|
|
|
16,225 |
|
GOODWILL |
|
|
15,535 |
|
|
|
15,535 |
|
INVESTMENTS |
|
|
14,794 |
|
|
|
14,960 |
|
DEFERRED INCOME TAXES |
|
|
44,618 |
|
|
|
15,832 |
|
OTHER ASSETS |
|
|
347 |
|
|
|
307 |
|
TOTAL ASSETS |
|
$ |
727,170 |
|
|
$ |
627,559 |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
13,780 |
|
|
$ |
8,112 |
|
Accrued expenses |
|
|
20,694 |
|
|
|
19,845 |
|
Deferred revenue |
|
|
10,603 |
|
|
|
10,282 |
|
Other current liabilities |
|
|
1,199 |
|
|
|
1,967 |
|
Total current liabilities |
|
|
46,276 |
|
|
|
40,206 |
|
DEFERRED REVENUE |
|
|
25,658 |
|
|
|
31,322 |
|
RETIREMENT PLAN BENEFIT LIABILITY |
|
|
32,226 |
|
|
|
27,563 |
|
Total liabilities |
|
|
104,160 |
|
|
|
99,091 |
|
COMMITMENTS AND CONTINGENCIES (Note 14) |
|
|
|
|
|
|
|
|
SHAREHOLDERS’ EQUITY: |
|
|
|
|
|
|
|
|
Preferred Stock, par value $0.01 per share, 5,000,000 shares authorized, 200,000 shares of Series A Nonconvertible Preferred Stock issued and outstanding (liquidation value of $7.50 per share or $1,500) |
|
|
2 |
|
|
|
2 |
|
Common Stock, par value $0.01 per share, 100,000,000 shares authorized, 48,466,087 and 48,270,990 shares issued, and 47,108,224 and 46,913,127 shares outstanding, at September 30, 2017 and December 31, 2016, respectively |
|
|
485 |
|
|
|
483 |
|
Additional paid-in capital |
|
|
606,415 |
|
|
|
604,364 |
|
Retained earnings (accumulated deficit) |
|
|
67,725 |
|
|
|
(25,557 |
) |
Accumulated other comprehensive loss |
|
|
(11,459 |
) |
|
|
(10,666 |
) |
Treasury stock, at cost (1,357,863 shares at September 30, 2017 and December 31, 2016) |
|
|
(40,158 |
) |
|
|
(40,158 |
) |
Total shareholders’ equity |
|
|
623,010 |
|
|
|
528,468 |
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
$ |
727,170 |
|
|
$ |
627,559 |
|
The accompanying notes are an integral part of these consolidated financial statements.
1
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)
(in thousands, except share and per share data)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
REVENUE: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Material sales |
|
$ |
47,041 |
|
|
$ |
23,465 |
|
|
$ |
140,506 |
|
|
$ |
70,084 |
|
Royalty and license fees |
|
|
12,013 |
|
|
|
5,209 |
|
|
|
72,705 |
|
|
|
52,569 |
|
Contract research services |
|
|
2,629 |
|
|
|
1,540 |
|
|
|
6,551 |
|
|
|
1,656 |
|
Total revenue |
|
|
61,683 |
|
|
|
30,214 |
|
|
|
219,762 |
|
|
|
124,309 |
|
COST OF SALES |
|
|
13,465 |
|
|
|
6,458 |
|
|
|
37,762 |
|
|
|
17,194 |
|
Gross margin |
|
|
48,218 |
|
|
|
23,756 |
|
|
|
182,000 |
|
|
|
107,115 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
11,596 |
|
|
|
10,118 |
|
|
|
34,099 |
|
|
|
31,562 |
|
Selling, general and administrative |
|
|
11,695 |
|
|
|
8,465 |
|
|
|
31,611 |
|
|
|
22,728 |
|
Amortization of acquired technology and other intangible assets |
|
|
5,498 |
|
|
|
5,461 |
|
|
|
16,485 |
|
|
|
11,039 |
|
Patent costs |
|
|
1,875 |
|
|
|
1,900 |
|
|
|
5,096 |
|
|
|
4,476 |
|
Royalty and license expense |
|
|
1,764 |
|
|
|
815 |
|
|
|
6,342 |
|
|
|
3,656 |
|
Total operating expenses |
|
|
32,428 |
|
|
|
26,759 |
|
|
|
93,633 |
|
|
|
73,461 |
|
OPERATING INCOME (LOSS) |
|
|
15,790 |
|
|
|
(3,003 |
) |
|
|
88,367 |
|
|
|
33,654 |
|
Interest income, net |
|
|
861 |
|
|
|
568 |
|
|
|
2,328 |
|
|
|
1,544 |
|
Other income (expense), net |
|
|
6 |
|
|
|
(68 |
) |
|
|
(7 |
) |
|
|
(1,982 |
) |
Interest and other income, net |
|
|
867 |
|
|
|
500 |
|
|
|
2,321 |
|
|
|
(438 |
) |
INCOME (LOSS) BEFORE INCOME TAXES |
|
|
16,657 |
|
|
|
(2,503 |
) |
|
|
90,688 |
|
|
|
33,216 |
|
INCOME TAX BENEFIT (EXPENSE) |
|
|
(3,137 |
) |
|
|
1,003 |
|
|
|
(19,616 |
) |
|
|
(10,965 |
) |
NET INCOME (LOSS) |
|
$ |
13,520 |
|
|
$ |
(1,500 |
) |
|
$ |
71,072 |
|
|
$ |
22,251 |
|
NET INCOME (LOSS) PER COMMON SHARE: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC |
|
$ |
0.28 |
|
|
$ |
(0.03 |
) |
|
$ |
1.50 |
|
|
$ |
0.47 |
|
DILUTED |
|
$ |
0.28 |
|
|
$ |
(0.03 |
) |
|
$ |
1.49 |
|
|
$ |
0.47 |
|
WEIGHTED AVERAGE SHARES USED IN COMPUTING NET INCOME (LOSS) PER COMMON SHARE: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BASIC |
|
|
46,801,051 |
|
|
|
46,947,621 |
|
|
|
46,716,726 |
|
|
|
46,889,913 |
|
DILUTED |
|
|
46,871,720 |
|
|
|
46,947,621 |
|
|
|
46,793,429 |
|
|
|
47,015,262 |
|
CASH DIVIDENDS DECLARED PER COMMON SHARE |
|
$ |
0.03 |
|
|
$ |
— |
|
|
$ |
0.09 |
|
|
$ |
— |
|
The accompanying notes are an integral part of these consolidated financial statements.
2
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
(in thousands)
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
NET INCOME (LOSS) |
|
$ |
13,520 |
|
|
$ |
(1,500 |
) |
|
$ |
71,072 |
|
|
$ |
22,251 |
|
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gain (loss) on available-for-sale securities, net of tax of $14, $92, $64 and $139, respectively |
|
|
27 |
|
|
|
(171 |
) |
|
|
117 |
|
|
|
(256 |
) |
Employee benefit plan: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Actuarial (loss) gain, net of tax of $154, $(5), $1,060 and $195, respectively |
|
|
(283 |
) |
|
|
(5 |
) |
|
|
(1,945 |
) |
|
|
(358 |
) |
Amortization of prior service cost and actuarial loss for retirement plan included in net periodic pension costs, net of tax of $199, $141, $549 and $443, respectively |
|
|
365 |
|
|
|
278 |
|
|
|
1,007 |
|
|
|
814 |
|
Net change for employee benefit plan |
|
|
82 |
|
|
|
273 |
|
|
|
(938 |
) |
|
|
456 |
|
Change in cumulative foreign currency translation adjustment |
|
|
3 |
|
|
|
12 |
|
|
|
28 |
|
|
|
32 |
|
TOTAL OTHER COMPREHENSIVE INCOME (LOSS) |
|
|
112 |
|
|
|
114 |
|
|
|
(793 |
) |
|
|
232 |
|
COMPREHENSIVE INCOME (LOSS) |
|
$ |
13,632 |
|
|
$ |
(1,386 |
) |
|
$ |
70,279 |
|
|
$ |
22,483 |
|
The accompanying notes are an integral part of these consolidated financial statements.
3
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF SHAREHOLDERS’ EQUITY
(UNAUDITED)
(in thousands, except for share data)
|
|
Series A Nonconvertible |
|
|
|
|
|
|
|
|
|
|
Additional |
|
|
|
|
|
|
Accumulated Other |
|
|
|
|
|
|
|
|
|
|
Total |
|
||||||||
|
|
Preferred Stock |
|
|
Common Stock |
|
|
Paid-in |
|
|
Retained |
|
|
Comprehensive |
|
|
Treasury Stock |
|
|
Shareholders’ |
|
|||||||||||||||||||
|
|
Shares |
|
|
Amount |
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Earnings |
|
|
Loss |
|
|
Shares |
|
|
Amount |
|
|
Equity |
|
||||||||||
BALANCE, DECEMBER 31, 2016 |
|
|
200,000 |
|
|
$ |
2 |
|
|
|
48,270,990 |
|
|
$ |
483 |
|
|
$ |
604,364 |
|
|
$ |
(25,557 |
) |
|
$ |
(10,666 |
) |
|
|
1,357,863 |
|
|
$ |
(40,158 |
) |
|
$ |
528,468 |
|
Cumulative effect of recording excess tax benefits from share-based payment arrangements |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
26,450 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
26,450 |
|
Net income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
71,072 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
71,072 |
|
Other comprehensive income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(793 |
) |
|
|
— |
|
|
|
— |
|
|
|
(793 |
) |
Cash dividend |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4,240 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4,240 |
) |
Exercise of common stock options |
|
|
— |
|
|
|
— |
|
|
|
1,750 |
|
|
|
— |
|
|
|
29 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
29 |
|
Issuance of common stock to employees |
|
|
— |
|
|
|
— |
|
|
|
263,154 |
|
|
|
2 |
|
|
|
8,478 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,480 |
|
Shares withheld for employee taxes |
|
|
— |
|
|
|
— |
|
|
|
(108,732 |
) |
|
|
— |
|
|
|
(9,330 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(9,330 |
) |
Issuance of common stock to Board of Directors and Scientific Advisory Board |
|
|
— |
|
|
|
— |
|
|
|
31,064 |
|
|
|
— |
|
|
|
2,190 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,190 |
|
Issuance of common stock to employees under an ESPP |
|
|
— |
|
|
|
— |
|
|
|
7,861 |
|
|
|
— |
|
|
|
684 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
684 |
|
BALANCE, SEPTEMBER 30, 2017 |
|
|
200,000 |
|
|
$ |
2 |
|
|
|
48,466,087 |
|
|
$ |
485 |
|
|
$ |
606,415 |
|
|
$ |
67,725 |
|
|
$ |
(11,459 |
) |
|
|
1,357,863 |
|
|
$ |
(40,158 |
) |
|
$ |
623,010 |
|
The accompanying notes are an integral part of these consolidated financial statements.
4
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
(in thousands)
|
|
Nine Months Ended September 30, |
|
|||||
|
|
2017 |
|
|
2016 |
|
||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
71,072 |
|
|
$ |
22,251 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Amortization of deferred revenue |
|
|
(7,206 |
) |
|
|
(5,281 |
) |
Depreciation |
|
|
3,638 |
|
|
|
3,002 |
|
Amortization of intangibles |
|
|
16,485 |
|
|
|
11,039 |
|
Amortization of premium and discount on investments, net |
|
|
(2,055 |
) |
|
|
(1,316 |
) |
Stock-based compensation to employees |
|
|
8,467 |
|
|
|
8,231 |
|
Stock-based compensation to Board of Directors and Scientific Advisory Board |
|
|
1,890 |
|
|
|
1,273 |
|
Change in earnout liability recorded for Adesis acquisition |
|
|
509 |
|
|
|
— |
|
Deferred income tax expense |
|
|
6,804 |
|
|
|
4,726 |
|
Retirement plan expense |
|
|
3,214 |
|
|
|
3,004 |
|
Decrease (increase) in assets: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(18,262 |
) |
|
|
3,723 |
|
Inventory |
|
|
(15,419 |
) |
|
|
(3,249 |
) |
Other current assets |
|
|
(2,835 |
) |
|
|
(4,977 |
) |
Other assets |
|
|
(40 |
) |
|
|
(249 |
) |
Increase (decrease) in liabilities: |
|
|
|
|
|
|
|
|
Accounts payable and accrued expenses |
|
|
3,904 |
|
|
|
(5,134 |
) |
Other current liabilities |
|
|
(768 |
) |
|
|
(5 |
) |
Deferred revenue |
|
|
1,863 |
|
|
|
3,296 |
|
Net cash provided by operating activities |
|
|
71,261 |
|
|
|
40,334 |
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(23,221 |
) |
|
|
(4,361 |
) |
Purchases of intangibles |
|
|
— |
|
|
|
(95,989 |
) |
Purchase of business, net of cash acquired |
|
|
— |
|
|
|
(33,163 |
) |
Purchases of investments |
|
|
(456,264 |
) |
|
|
(380,260 |
) |
Proceeds from sale of investments |
|
|
351,024 |
|
|
|
434,683 |
|
Net cash used in investing activities |
|
|
(128,461 |
) |
|
|
(79,090 |
) |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
|
529 |
|
|
|
317 |
|
Proceeds from the exercise of common stock options |
|
|
29 |
|
|
|
182 |
|
Payment of withholding taxes related to stock-based compensation to employees |
|
|
(9,330 |
) |
|
|
(4,840 |
) |
Cash dividends paid |
|
|
(4,240 |
) |
|
|
— |
|
Net cash used in financing activities |
|
|
(13,012 |
) |
|
|
(4,341 |
) |
DECREASE IN CASH AND CASH EQUIVALENTS |
|
|
(70,212 |
) |
|
|
(43,097 |
) |
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD |
|
|
139,365 |
|
|
|
97,513 |
|
CASH AND CASH EQUIVALENTS, END OF PERIOD |
|
$ |
69,153 |
|
|
$ |
54,416 |
|
The following non-cash activities occurred: |
|
|
|
|
|
|
|
|
Unrealized (gain) loss on available-for-sale securities |
|
$ |
(117 |
) |
|
$ |
256 |
|
Common stock issued to Board of Directors and Scientific Advisory Board that was earned and accrued for in a previous period |
|
|
300 |
|
|
|
300 |
|
Common stock issued to employees that was earned and accrued for in a previous period |
|
|
174 |
|
|
|
1,105 |
|
Net change in accounts payable and accrued expenses related to purchases of property and equipment |
|
|
2,572 |
|
|
|
133 |
|
Earnout liability recorded for Adesis acquisition |
|
|
— |
|
|
|
1,510 |
|
The accompanying notes are an integral part of these consolidated financial statements.
5
UNIVERSAL DISPLAY CORPORATION AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
1. |
BUSINESS: |
Universal Display Corporation (the Company) is a leader in the research, development and commercialization of organic light emitting diode (OLED) technologies and materials for use in display and solid-state lighting applications. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light that can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and as lighting products. OLED displays are capturing a growing share of the display market. The Company believes this is because OLEDs offer potential advantages over competing display technologies with respect to power efficiency, contrast ratio, viewing angle, video response time, form factor and manufacturing cost. The Company also believes that OLED lighting products have the potential to replace many existing light sources in the future because of their high power efficiency, excellent color rendering index, low operating temperature and novel form factor. The Company's technology leadership and intellectual property position should enable it to share in the revenues from OLED displays and lighting products as they enter mainstream consumer and other markets.
The Company's primary business strategy is to (1) further develop and license its proprietary OLED technologies to manufacturers of products for display applications, such as mobile phones, televisions, tablets, wearables, portable media devices, notebook computers, personal computers, and automotive interiors, and specialty and general lighting products; and (2) develop new OLED materials and sell existing and any new materials to those product manufacturers. The Company has established a significant portfolio of proprietary OLED technologies and materials, primarily through internal research and development efforts and acquisitions of patents and patent applications, as well as maintaining its relationships with world-class partners such as Princeton University (Princeton), the University of Southern California (USC), the University of Michigan (Michigan) and PPG Industries, Inc. (PPG Industries). The Company currently owns, exclusively licenses or has the sole right to sublicense more than 4,200 patents issued and pending worldwide.
The Company sells its proprietary OLED materials to customers for evaluation and use in commercial OLED products. The Company also enters into agreements with manufacturers of OLED display and lighting products under which it grants them licenses to practice under its patents and to use the Company's proprietary know-how. At the same time, the Company works with these and other companies who are evaluating the Company's OLED technologies and materials for possible use in commercial OLED display and lighting products.
2. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: |
Interim Financial Information
In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the Company’s financial position as of September 30, 2017 and results of operations for the three and nine months ended September 30, 2017 and 2016, and cash flows for the nine months ended September 30, 2017 and 2016. While management believes that the disclosures presented are adequate to make the information not misleading, these unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto in the Company’s latest year-end financial statements, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. The results of the Company’s operations for any interim period are not necessarily indicative of the results of operations for any other interim period or for the full year.
Principles of Consolidation
The consolidated financial statements include the accounts of Universal Display Corporation and its wholly owned subsidiaries, UDC, Inc., UDC Ireland Limited, Universal Display Corporation Hong Kong, Limited, Universal Display Corporation Korea, Y.H., Universal Display Corporation Japan GK, Universal Display Corporation China, Ltd. and Adesis, Inc. (Adesis). All intercompany transactions and accounts have been eliminated.
Business Combinations
Accounting for acquisitions requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed at the acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While the Company uses its best
6
estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which is the period when all information necessary is obtained, but not to exceed one year from the acquisition date, adjustments may be recorded to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of income.
Management’s Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The estimates made are principally in the areas of revenue recognition for license agreements, the useful life of acquired intangibles, the use and recoverability of inventories, intangibles and income taxes including realization of deferred tax assets, stock-based compensation and retirement benefit plan liabilities. Actual results could differ from those estimates.
Inventories
Inventories consist of raw materials, work-in-process and finished goods, including inventory consigned to customers, and are stated at the lower of cost, determined on a first-in, first-out basis, or market. Inventory valuation and firm committed purchase order assessments are performed on a quarterly basis and those items that are identified to be obsolete or in excess of forecasted usage are written down to their estimated realizable value. Estimates of realizable value are based upon management’s analyses and assumptions, including, but not limited to, forecasted sales levels by product, expected product lifecycle, product development plans and future demand requirements. A 12-month rolling forecast based on factors, including, but not limited to, production cycles, anticipated product orders, marketing forecasts, backlog, and shipment activities is used in the inventory analysis. If market conditions are less favorable than forecasts or actual demand from customers is lower than estimates, additional inventory write-downs may be required. If demand is higher than expected, inventories that had previously been written down may be sold.
Certain of the Company’s customers have assumed the responsibility for maintaining the Company's inventory at their location based on the customers’ demand forecast. Notwithstanding the fact that the Company builds and ships the inventory, the customer does not purchase the consigned inventory until the inventory is drawn or pulled by the customer to be used in the manufacture of the customer’s product. Though the consigned inventory may be at the customer’s physical location, it remains inventory owned by the Company until the inventory is drawn or pulled, which is the time at which the sale takes place.
Fair Value of Financial Instruments
The carrying values of accounts receivable, other current assets, and accounts payable approximate fair value in the accompanying financial statements due to the short-term nature of those instruments. The Company’s other financial instruments, which include cash equivalents and investments, are carried at fair value.
Revenue Recognition and Deferred Revenue
Material sales relate to the Company’s sale of its OLED materials for incorporation into its customers’ commercial OLED products or for their OLED development and evaluation activities. Material sales are recognized at the time title passes, which is typically at the time of shipment or at the time of delivery, depending upon the contractual agreement between the parties.
The Company receives license and royalty payments under certain commercial, development and technology evaluation agreements, some of which are non-refundable. These payments may include royalty and license fees made pursuant to license agreements and certain commercial supply agreements. Amounts received are deferred and classified as either current or non-current deferred revenue based upon current contractual remaining terms; however, based upon on-going relationships with customers, as well as future agreement extensions and other factors, amounts classified as current as of September 30, 2017 may not be recognized as revenue over the next twelve months. For arrangements with extended payment terms where the fee is not fixed and determinable, the Company recognizes revenue when the payment is due and payable. Royalty revenue and license fees included as part of commercial supply agreements are recognized when earned and the amount is fixed and determinable. If the Company used different estimates for the useful life of the licensed technology, or if fees are fixed and determinable, reported revenue during the relevant period would differ.
Contract research services revenue is revenue earned by performing organic and organometallic synthetics research, development and commercialization on a contractual basis. These services range from intermediates for structure-activity relationship
7
studies, reference agents and building blocks for combinatorial synthesis, re-synthesis of key intermediates, specialty organic chemistry needs, and selective toll manufacturing. These services are provided to third-party pharmaceutical and life sciences firms and other technology firms at fixed costs or on an annual contract basis. Revenue is recognized as services are performed with billing schedules and payment terms negotiated on a contract-by-contract basis. Payments received in excess of revenue recognized are recorded as deferred revenue. In other cases, services may be provided and revenue is recognized before the client is invoiced. In these cases, revenue recognized will exceed amounts billed and the difference, representing amounts which are currently unbillable to the customer pursuant to contractual terms, is recorded as an unbilled receivable.
Technology development and support revenue is revenue earned from government contracts, development and technology evaluation agreements and commercialization assistance fees, which includes reimbursements by government entities for all or a portion of the research and development costs the Company incurs in relation to its government contracts. Revenues are recognized proportionally as research and development costs are incurred, or as defined milestones are achieved, and are included in contract research services in the accompanying consolidated statements of income.
Currently, the Company's most significant commercial license agreement, which runs through the end of 2017, is with Samsung Display Co., Ltd. (SDC) and covers the manufacture and sale of specified OLED display products. Under this agreement, the Company is being paid a license fee, payable in semi-annual installments over the agreement term of 6.4 years. The installments, which are due in the second and fourth quarter of each year, increase on an annual basis over the term of the agreement. The agreement conveys to SDC the non-exclusive right to use certain of the Company's intellectual property assets for a limited period of time that is less than the estimated life of the assets. Ratable recognition of revenue is impacted by the agreement's extended increasing payment terms in light of the Company's limited history with similar agreements. As a result, revenue is recognized at the lesser of the proportional performance approach (ratable) and the amount of due and payable fees from SDC. Given the increasing contractual payment schedule, license fees under the agreement are recognized as revenue when they become due and payable, which is currently scheduled to be in the second and fourth quarter of each year.
At the same time the Company entered into the current patent license agreement with SDC, the Company also entered into a new supplemental material purchase agreement with SDC. Under the current supplemental material purchase agreement, SDC agrees to purchase from the Company a minimum dollar amount of phosphorescent emitter materials for use in the manufacture of licensed products. This minimum purchase commitment is subject to SDC’s requirements for phosphorescent emitter materials and the Company’s ability to meet these requirements over the term of the supplemental agreement. The minimum purchase amounts increase on an annual basis over the term of the supplemental agreement. These amounts were determined through negotiation based on a number of factors, including, without limitation, estimates of SDC’s OLED business growth as a percentage of published OLED market forecasts and SDC’s projected minimum usage of red and green phosphorescent emitter materials over the term of the agreement.
In 2015, the Company entered into an OLED patent license agreement and an OLED commercial supply agreement with LG Display Co., Ltd. (LG Display) which were effective as of January 1, 2015 and superseded the 2007 commercial supply agreement between the parties. The new agreements have a term that is set to expire by the end of 2022. The patent license agreement provides LG Display a non-exclusive, royalty bearing portfolio license to make and sell OLED displays under the Company's patent portfolio. The patent license calls for license fees, prepaid royalties and running royalties on licensed products. The prepaid royalty amount is included in deferred revenue and a portion of this amount can be credited against total royalties due over the life of the contract. The agreements include customary provisions relating to warranties, indemnities, confidentiality, assignability and business terms. The agreements provide for certain other minimum obligations relating to the volume of material sales anticipated over the term of the agreements, as well as minimum royalty revenue to be generated under the patent license agreement. The Company expects to generate revenue under these agreements that are predominantly tied to LG Display’s sales of OLED licensed products. The OLED commercial supply agreement provides for the sale of materials for use by LG Display, which may include phosphorescent dopants and host materials.
In 2016, the Company entered into an OLED Technology License Agreement and Commercial Material Supply Agreement with Tianma Micro-electronics Co., Ltd. (Tianma) which were both effective July 21, 2016 and run for five years. Under the license agreement, the Company has granted Tianma non-exclusive license rights under various patents owned or controlled by the Company to manufacture and sell OLED display products. The license agreement calls for license fees and running royalties on licensed products. Additionally, the agreement provides for the sale of phosphorescent OLED materials to Tianma for use in its licensed products.
The Company records taxes billed to customers and remitted to various governmental entities on a gross basis in both revenues and cost of material sales in the consolidated statements of income. The amounts of these pass through taxes reflected in revenues and cost of material sales were $97,000 and $304,000 for the three and nine months ended September 30, 2017, respectively, and $74,000 and $143,000 for the three and nine months ended September 30, 2016, respectively.
8
All sales transactions are billed and due within 90 days and substantially all are transacted in U.S. dollars.
Cost of Sales
Cost of sales consists of labor and material costs associated with the production of materials processed at the Company's manufacturing partners and at the Company's internal manufacturing processing facility. The Company’s portion of cost of sales also includes depreciation of manufacturing equipment, as well as manufacturing overhead costs and inventory adjustments for excess and obsolete inventory.
Research and Development
Expenditures for research and development are charged to expense as incurred.
Patent Costs
Costs associated with patent applications, patent prosecution, patent defense and the maintenance of patents are charged to expense as incurred. Costs to successfully defend a challenge to a patent are capitalized to the extent of an evident increase in the value of the patent. Costs that relate to an unsuccessful outcome are charged to expense.
Amortization of Acquired Technology
Amortization costs relate to technology acquired from BASF, Fujifilm and Motorola. These acquisitions were completed in the years ended December 31, 2016, 2012 and 2011, respectively. Acquisition costs are being amortized over a period of 10 years for the BASF and Fujifilm patents and 7.5 years for the Motorola patents.
Amortization of Other Intangible Assets
Other intangible assets from the Adesis acquisition are being amortized over a period of 10 to 15 years. See Note 7 for further discussion.
Translation of Foreign Currency Financial Statements and Foreign Currency Transactions
The Company's reporting currency is the U.S. dollar. The functional currency for the Company's Ireland subsidiary is also the U.S. dollar and the functional currency for each of the Company's Asia-Pacific foreign subsidiaries is its local currency. The Company translates the amounts included in the consolidated statements of income from its Asia-Pacific foreign subsidiaries into U.S. dollars at weighted-average exchange rates, which the Company believes are representative of the actual exchange rates on the dates of the transactions. The Company's foreign subsidiaries' assets and liabilities are translated into U.S. dollars from the local currency at the actual exchange rates as of the end of each reporting date, and the Company records the resulting foreign exchange translation adjustments in the consolidated balance sheets as a component of accumulated other comprehensive loss. The overall effect of the translation of foreign currency and foreign currency transactions to date has been insignificant.
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount of which the likelihood of realization is greater than 50%. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company records interest and penalties, if any, related to unrecognized tax benefits as a component of tax expense.
Share-Based Payment Awards
The Company recognizes in the consolidated statements of income the grant-date fair value of equity based awards such as shares issued under employee stock purchase plans, restricted stock awards, restricted stock units and performance unit awards issued to employees and directors.
9
The grant-date fair value of stock awards is based on the closing price of the stock on the date of grant. The fair value of share-based awards is recognized as compensation expense on a straight-line basis over the requisite service period, net of forfeitures. The Company issues new shares upon the respective grant, exercise or vesting of the share-based payment awards, as applicable.
Performance unit awards are subject to either a performance-based or market-based vesting requirement. For performance-based vesting, the grant-date fair value of the award, based on fair value of the Company's common stock, is recognized over the service period based on an assessment of the likelihood that the applicable performance goals will be achieved and compensation expense is periodically adjusted based on actual and expected performance. Compensation expense for performance unit awards with market-based vesting is calculated based on the estimated fair value as of the grant date utilizing a Monte Carlo simulation model and is recognized over the service period on a straight-line basis.
Recent Accounting Pronouncements
In May 2014, the Financial Accounting Standards Board (FASB) issued a new revenue recognition standard entitled Revenue from Contracts with Customers. The objective of the standard is to establish the principles that an entity shall apply to report useful information to users of financial statements about the nature, amount, timing, and uncertainty of revenue and cash flows from a contract with a customer. The standard is effective for annual reporting periods beginning after December 15, 2017. Earlier adoption as of the original date is optional; however, the Company will adopt the standard beginning January 1, 2018. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements. The Company is currently analyzing the impact of the new standard on the Company’s revenue contracts, comparing its current accounting policies and practices to the requirements of the new standard, and identifying potential differences that would result from applying the new standard to its contracts. The Company plans to use the “modified retrospective” adoption method. The Company’s most significant license contract expires at the end of 2017 and is anticipated for renewal as of approximately January 1, 2018. As such, the renewed contract will be accounted for in accordance with the new revenue recognition standard. The Company is also identifying and implementing changes to the Company’s business processes, systems and controls to support adoption of the new standard in 2018.
In November 2015, the FASB issued ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes, which requires the classification of all deferred tax assets and liabilities as noncurrent rather than separately disclosing deferred taxes as current and noncurrent. The standard is effective for annual reporting periods beginning after December 15, 2016. The standard allows for either “prospective” adoption, meaning the standard is applied to the most current period presented in the financial statements or “full retrospective” adoption, meaning the standard is applied to all periods presented. The Company adopted ASU 2015-17 effective January 1, 2017 on a “prospective” basis.
In February 2016, the FASB issued ASU No. 2016-02, Leases, which addresses the classification and recognition of lease assets and liabilities formerly classified as operating leases under generally accepted accounting principles. The guidance will address certain aspects of recognition and measurement, and quantitative and qualitative aspects of presentation and disclosure. The guidance is effective for fiscal years beginning after December 31, 2018, including interim periods within those fiscal years. The Company is evaluating the effect that ASU 2016-02 may have on its consolidated financial statements and related disclosures.
In March 2016, the FASB issued ASU No. 2016-09, Improvements to Employee Share-Based Accounting. The objective of the standard is to simplify the accounting and related disclosures associated with employee share-based accounting. The standard is effective for annual reporting periods beginning after December 15, 2016. The ASU requires prospective adoption, meaning the standard is applied to the most current period presented in the financial statements. The Company adopted ASU 2016-09 effective January 1, 2017 and recorded a deferred tax asset and offsetting credit to retained earnings of $26.5 million (see Note 10).
In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. The objective of the standard is to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The ASU provides additional clarification guidance on the classification of certain cash receipts and payments in the statement of cash flows. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2017, with early adoption permitted. The Company is evaluating the effect that ASU 2016-15 may have on its consolidated financial statements and related disclosures.
In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. ASU 2016-16 clarifies the accounting for the current and deferred income taxes for an intra-entity transfer of an asset other than inventory. ASU 2016-16 is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, with early adoption permitted. The Company is evaluating the effect that ASU 2016-16 may have on its consolidated financial statements and related disclosures.
10
In January 2017, the FASB issued ASU No. 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test of Goodwill Impairment eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standards update is effective prospectively for annual and interim goodwill impairment testing performed in fiscal years beginning after December 15, 2019, with early adoption permitted. The Company is evaluating the effect that ASU 2017-04 may have on its consolidated financial statements and related disclosures.
In May 2017, the FASB issued ASU 2017-09, Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting. ASU 2017-09 clarifies which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting, in accordance with Topic 718. The guidance is effective for annual periods beginning after December 15, 2017, with early adoption permitted, and requires a prospective application to awards modified on or after the adoption date. The Company has not historically made changes to the terms or conditions of shared-based payment awards and does not expect adoption of ASU 2017-09 to have a material impact on the consolidated financial statements and related disclosures.
3. |
BUSINESS COMBINATIONS: |
On June 23, 2016, the Company entered into an agreement to acquire Adesis, a privately held contract research organization (CRO) with 43 employees specializing in organic and organometallic synthetic research, development, and commercialization. Adesis is a technology vendor to companies in the pharmaceutical, fine chemical, biomaterials, and catalyst industries, and has worked with the Company over the last few years to help advance and accelerate a number of the Company’s product offerings. The transaction closed on July 11, 2016. Under the terms of the agreement, the Company’s subsidiary, UDC, Inc., acquired all outstanding shares of Adesis in a merger for $33.9 million in cash, and up to an additional $2.4 million in cash contingent upon Adesis’ achievement of certain milestones within two years of the acquisition. The acquisition was funded through use of existing cash and investments.
Purchase Price Allocation
The Company accounted for Adesis using the acquisition method of accounting in accordance with applicable U.S. GAAP whereby the total purchase price was allocated to tangible and intangible assets acquired and liabilities assumed based on respective fair values. The contingent consideration arrangement requires the Company to pay up to $1.2 million of additional consideration to the former shareholders of Adesis if revenues exceed certain threshold levels at the end of each twelve-month period ending December 31, 2016 and December 31, 2017. For the year ended December 31, 2016, the additional cash consideration earned by the former shareholders of Adesis was $1.2 million. The fair value of the contingent consideration was derived using a Monte Carlo simulation model based on management’s projections of future revenue levels. The following table summarizes the values of the assets acquired and liabilities assumed at the date of acquisition (in thousands):
Cash consideration |
|
$ |
33,872 |
|
Contingent consideration |
|
|
1,670 |
|
|
|
$ |
35,542 |
|
Allocation of purchase price: |
|
|
|
|
Current assets, including cash of $492 |
|
$ |
2,204 |
|
Property and equipment |
|
|
1,869 |
|
Accounts payable and accrued liabilities |
|
|
(906 |
) |
Net tangible assets |
|
|
3,167 |
|
Identifiable intangible assets |
|
|
16,840 |
|
Goodwill |
|
|
15,535 |
|
Total purchase price |
|
$ |
35,542 |
|
The purchase price exceeded the fair value of the net tangible assets and identifiable intangible assets acquired and, as a result, the Company recorded goodwill in connection with this transaction. This difference includes a going concern element that represents the Company’s ability to earn a higher rate of return on this group of assets than would be expected on the separate assets as determined during the valuation process.
Transaction costs of $360,000 were recorded and charged to selling, general and administrative expense on the accompanying consolidated statements of operations during 2016.
11
The following table presents the intangible assets identified in the transaction:
Category |
|
Estimated fair value (in thousands) |
|
|
Estimated useful life (in years) |
|
||
Customer relationships |
|
|
10,520 |
|
|
|
11.5 |
|
Internally-developed IP, processes and recipes |
|
|
4,820 |
|
|
|
15.0 |
|
Trade name/Trademarks |
|
|
1,500 |
|
|
|
10.0 |
|
Total identifiable intangible assets |
|
$ |
16,840 |
|
|
|
|
|
The fair value of the customer relationships asset was determined using the income approach through an excess earnings analysis which estimates value based on the present value of future economic benefits. The customer relationships intangible asset represents relationships between Adesis and its customers. The fair value of the internally-developed IP, processes and recipes was determined by utilizing the relief-from-royalty methodology. The fair value of the Adesis trade name asset was determined using the income approach through a relief-from-royalty analysis. The determination of useful lives was based upon consideration of market participant assumptions and transaction specific factors.
4. |
CASH, CASH EQUIVALENTS AND INVESTMENTS: |
The Company considers all highly liquid debt instruments purchased with an original maturity of three months or less to be cash equivalents. The Company classifies its remaining investments as available-for-sale. These securities are carried at fair market value, with unrealized gains and losses reported in shareholders’ equity. Gains or losses on securities sold are based on the specific identification method. Investments as of September 30, 2017 and December 31, 2016 consisted of the following (in thousands):
|
|
Amortized |
|
|
Unrealized |
|
|
Aggregate Fair |
|
|||||||
Investment Classification |
|
Cost |
|
|
Gains |
|
|
(Losses) |
|
|
Market Value |
|
||||
September 30, 2017 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit |
|
$ |
1,230 |
|
|
$ |
2 |
|
|
$ |
— |
|
|
$ |
1,232 |
|
Commercial paper |
|
|
— |
|
|
|
— |
|
|
|
0 |
|
|
|
— |
|
Corporate bonds |
|
|
69,886 |
|
|
|
6 |
|
|
|
(206 |
) |
|
|
69,686 |
|
U.S. Government securities |
|
|
245,147 |
|
|
|
25 |
|
|
|
(17 |
) |
|
|
245,155 |
|
|
|
$ |
316,263 |
|
|
$ |
33 |
|
|
$ |
(223 |
) |
|
$ |
316,073 |
|
December 31, 2016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Certificates of deposit |
|
$ |
3,362 |